These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7210329)

  • 1. [A preliminary study of bufexamac in pediatric dermatology].
    Ricard P; Perras M; Proulx C
    Union Med Can; 1980 Aug; 109(8):1208-11. PubMed ID: 7210329
    [No Abstract]   [Full Text] [Related]  

  • 2. General dermatologic use of hydroxamic acid.
    Solano E
    Clin Ther; 1980; 3(4):229-33. PubMed ID: 7273060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inflamed dermatoses. Treatment with Bufexamac. A randomized comparative double-blind study against fluocortinbutyl ester].
    Vakilzadeh F; Macher E
    ZFA (Stuttgart); 1983 Nov; 59(33):1888-91. PubMed ID: 6362257
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
    Christiansen JV; Gadborg E; Kleiter I; Ludvigsen K; Meier CH; Norholm A; Reiter H; Reymann F; Raaschou-Nielsen W; Sondergaard M; Unna P; Wehnert R
    Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
    Schnuch A; Gefeller O; Uter W
    Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial.
    Fine JD; Johnson L
    Arch Dermatol; 1988 Nov; 124(11):1669-72. PubMed ID: 3178249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bufexamac cream and ointment for the treatment of various dermatoses].
    Achten G; Bourlond A; Haven E; Lapière CM; Piérard J; Reynaers H
    Dermatologica; 1973; 146(1):1-7. PubMed ID: 4571591
    [No Abstract]   [Full Text] [Related]  

  • 8. Bufexamac in the treatment of skin diseases in general practice.
    Valle-Jones JC
    Practitioner; 1974 Sep; 213(1275):383-6. PubMed ID: 4609377
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new non-steroid anti-inflammatory agent in therapy of osteoarthrosis].
    Loizzi P
    Clin Ter; 1980 Mar; 92(5):497-512. PubMed ID: 7004750
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of a 2% glycyrrhetinic acid cream in pediatric dermatology].
    Queille C; Raynaud F
    Ann Pediatr (Paris); 1982 Oct; 29(8):599-601. PubMed ID: 7181402
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

  • 12. Contact dermatitis to bufexamac.
    Reiffers J
    Dermatologica; 1982 May; 164(5):354-6. PubMed ID: 7095225
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of bufexamac suppositories in rectal conditions.
    Samsi AB
    J Postgrad Med; 1975 Jul; 21(3):131-4. PubMed ID: 1206602
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
    Shaw M; Morrell DS; Goldsmith LA
    Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contact dermatitis due to bufexamac.
    Melino M; Bardazzi F; Manuzzi P
    Contact Dermatitis; 1987 May; 16(5):287. PubMed ID: 2957160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of a bufexamac-nystatin-neomycin combination in dermatology].
    Aussems J
    Brux Med; 1972 Nov; 52(11):797-9. PubMed ID: 4569897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary study of the action of p-butoxyphenylacethydroxamic acid (Bufexamac) in the treatment of coxarthrosis].
    Bloch-Michel H; Parrot M
    Therapie; 1970; 25(5):969-75. PubMed ID: 5486155
    [No Abstract]   [Full Text] [Related]  

  • 19. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.
    Suh L; Coffin S; Leckerman KH; Gelfand JM; Honig PJ; Yan AC
    Pediatr Dermatol; 2008; 25(5):528-34. PubMed ID: 18950393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.
    Mailhol C; Lauwers-Cances V; Rancé F; Paul C; Giordano-Labadie F
    Allergy; 2009 May; 64(5):801-6. PubMed ID: 19183418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.